{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T05:39:25Z","timestamp":1792474765488,"version":"4.5.0"},"reference-count":141,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.hoc.2014.10.003","type":"journal-article","created":{"date-parts":[[2014,12,16]],"date-time":"2014-12-16T20:00:21Z","timestamp":1418760021000},"page":"271-288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Diagnosis and Management of Upper Tract Urothelial Carcinoma"],"prefix":"10.1016","volume":"29","author":[{"given":"Ilaria","family":"Lucca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J.","family":"Leow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven L.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.hoc.2014.10.003_bib1","first-page":"9","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"10.1016\/j.hoc.2014.10.003_bib2","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1464-410X.2010.09675.x","article-title":"Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973-2005","volume":"107","author":"Raman","year":"2011","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.hoc.2014.10.003_bib3","first-page":"1523","article-title":"Upper tract urothelial neoplasms: incidence and survival during the last 2 decades","volume":"164","author":"Munoz","year":"2000","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.hoc.2014.10.003_bib4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00345-012-0877-2","article-title":"Upper urinary tract urothelial cell carcinoma: location as a predictive factor for concomitant bladder carcinoma","volume":"31","author":"Cosentino","year":"2013","journal-title":"World J Urol"},{"issue":"4","key":"10.1016\/j.hoc.2014.10.003_bib5","first-page":"1214","article-title":"Urothelial carcinoma of the bladder and the upper tract: disparate twins","volume":"189","author":"Green","year":"2013","journal-title":"J\u00a0Urol"},{"issue":"10","key":"10.1016\/j.hoc.2014.10.003_bib6","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1111\/j.1464-410X.2009.08838.x","article-title":"Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract","volume":"104","author":"Colin","year":"2009","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.hoc.2014.10.003_bib7","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1442-2042.1995.tb00465.x","article-title":"Factors affecting the occurrence of urothelial tumors in dye workers exposed to aromatic amines","volume":"2","author":"Shinka","year":"1995","journal-title":"Int J Urol"},{"issue":"1","key":"10.1016\/j.hoc.2014.10.003_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/em.21756","article-title":"Aristolochic acid nephropathy: Harbinger of a global iatrogenic disease","volume":"54","author":"Grollman","year":"2013","journal-title":"Environ Mol Mutagen"},{"issue":"1","key":"10.1016\/j.hoc.2014.10.003_bib9","doi-asserted-by":"crossref","first-page":"28.e11","DOI":"10.1016\/j.urolonc.2012.10.002","article-title":"Molecular aspects of upper tract urothelial carcinoma","volume":"32","author":"Patel","year":"2014","journal-title":"Urol Oncol"},{"issue":"3","key":"10.1016\/j.hoc.2014.10.003_bib10","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00432-014-1585-7","article-title":"Risk factors and treatment outcomes of new contralateral upper urinary urothelial carcinoma after nephroureterectomy: the experiences of a large Chinese center","volume":"140","author":"Fang","year":"2014","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"issue":"6","key":"10.1016\/j.hoc.2014.10.003_bib11","doi-asserted-by":"crossref","first-page":"469","DOI":"10.7326\/0003-4819-158-6-201303190-00006","article-title":"The epidemiology, diagnosis, and management of aristolochic acid nephropathy: a narrative review","volume":"158","author":"Gokmen","year":"2013","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.hoc.2014.10.003_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.mrrev.2013.02.003","article-title":"Analysis of TP53 mutation spectra reveals the fingerprint of the potent environmental carcinogen, aristolochic acid","volume":"753","author":"Hollstein","year":"2013","journal-title":"Mutat Res"},{"issue":"21","key":"10.1016\/j.hoc.2014.10.003_bib13","doi-asserted-by":"crossref","first-page":"8241","DOI":"10.1073\/pnas.1119920109","article-title":"Aristolochic acid-associated urothelial cancer in Taiwan","volume":"109","author":"Chen","year":"2012","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"3","key":"10.1016\/j.hoc.2014.10.003_bib14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.urolonc.2013.08.029","article-title":"Highlights from the first symposium on upper tract urothelial carcinoma","volume":"32","author":"Matin","year":"2014","journal-title":"Urol Oncol"},{"issue":"6","key":"10.1016\/j.hoc.2014.10.003_bib15","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.eururo.2008.08.008","article-title":"Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum","volume":"54","author":"Roupret","year":"2008","journal-title":"Eur Urol"},{"issue":"11 Pt B","key":"10.1016\/j.hoc.2014.10.003_bib16","first-page":"E583","article-title":"A\u00a0proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi-institutional database analysis: proposal of patient-specific risk identification tool","volume":"110","author":"Audenet","year":"2012","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.hoc.2014.10.003_bib17","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/bju.12597","article-title":"Preoperative predictors of renal function decline following radical nephroureterectomy for upper tract urothelial carcinoma","volume":"114","author":"Kaag","year":"2014","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.hoc.2014.10.003_bib18","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.eururo.2013.03.032","article-title":"European guidelines on upper tract urothelial carcinomas: 2013 update","volume":"63","author":"Roupret","year":"2013","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.hoc.2014.10.003_bib19","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1148\/radiol.2472070798","article-title":"Small (<2-cm) upper-tract urothelial carcinoma: evaluation with gadolinium-enhanced three-dimensional spoiled gradient-recalled echo MR urography","volume":"247","author":"Takahashi","year":"2008","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.hoc.2014.10.003_bib20","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1007\/s00330-008-1228-y","article-title":"MR urography for suspected upper tract urothelial carcinoma","volume":"19","author":"Takahashi","year":"2009","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.hoc.2014.10.003_bib21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1089\/end.2007.9853","article-title":"Correlation of upper-tract cytology, retrograde pyelography, ureteroscopic appearance, and ureteroscopic biopsy with histologic examination of upper-tract transitional cell carcinoma","volume":"22","author":"Williams","year":"2008","journal-title":"J\u00a0Endourol"},{"issue":"5","key":"10.1016\/j.hoc.2014.10.003_bib22","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1464-410X.2010.09899.x","article-title":"Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma","volume":"108","author":"Messer","year":"2011","journal-title":"BJU Int"},{"issue":"8","key":"10.1016\/j.hoc.2014.10.003_bib23","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1089\/end.2013.0703","article-title":"Routine diagnostic ureteroscopy for suspected upper tract transitional-cell carcinoma","volume":"28","author":"Tsivian","year":"2014","journal-title":"J\u00a0Endourol"},{"issue":"12","key":"10.1016\/j.hoc.2014.10.003_bib24","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1089\/end.2013.0220","article-title":"Ureteroscopic biopsy of upper tract urothelial carcinoma: comparison of basket and forceps","volume":"27","author":"Kleinmann","year":"2013","journal-title":"J\u00a0Endourol"},{"issue":"1","key":"10.1016\/j.hoc.2014.10.003_bib25","first-page":"356","article-title":"Prevalence and management of complications of ureteroscopy: a seven-year experience with introduction of a new maneuver to prevent ureteral avulsion","volume":"9","author":"Taie","year":"2012","journal-title":"Urol J"},{"issue":"Suppl 1","key":"10.1016\/j.hoc.2014.10.003_bib26","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.ijantimicag.2003.09.005","article-title":"Controversies in antibiotic prophylaxis in urology","volume":"23","author":"Grabe","year":"2004","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.hoc.2014.10.003_bib27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00345-012-0959-1","article-title":"The oncologic impact of a delay between diagnosis and radical nephroureterectomy due to diagnostic ureteroscopy in upper urinary tract urothelial carcinomas: results from a large collaborative database","volume":"31","author":"Nison","year":"2013","journal-title":"World J Urol"},{"issue":"3","key":"10.1016\/j.hoc.2014.10.003_bib28","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/iju.12267","article-title":"Survival after nephroureterectomy for upper tract urothelial carcinoma: a population-based competing-risks analysis","volume":"21","author":"Gandaglia","year":"2014","journal-title":"Int J Urol"},{"issue":"2","key":"10.1016\/j.hoc.2014.10.003_bib29","first-page":"1435","article-title":"Postoperative nomogram for disease recurrence and cancer-specific death for upper tract urothelial carcinoma: comparison to American Joint Committee on Cancer staging classification","volume":"11","author":"Ehdaie","year":"2014","journal-title":"Urol J"},{"issue":"5","key":"10.1016\/j.hoc.2014.10.003_bib30","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/bju.12631","article-title":"Postoperative nomogram to predict cancer-specific survival after radical nephroureterectomy in patients with localised and\/or locally advanced upper tract urothelial carcinoma without metastasis","volume":"114","author":"Seisen","year":"2014","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.hoc.2014.10.003_bib31","first-page":"1662","article-title":"Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis","volume":"189","author":"Roupret","year":"2013","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.hoc.2014.10.003_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2014.04.008","article-title":"Comparative analysis of comorbidity and performance indices for prediction of oncological outcomes in patients with upper tract urothelial carcinoma who were treated with radical nephroureterectomy","author":"Aziz","year":"2014","journal-title":"Urol Oncol"},{"issue":"5","key":"10.1016\/j.hoc.2014.10.003_bib33","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.eururo.2010.07.034","article-title":"Predictive and prognostic models in radical prostatectomy candidates: a critical analysis of the literature","volume":"58","author":"Lughezzani","year":"2010","journal-title":"Eur Urol"},{"issue":"8 Pt 2","key":"10.1016\/j.hoc.2014.10.003_bib34","doi-asserted-by":"crossref","first-page":"E304","DOI":"10.1111\/j.1464-410X.2011.10188.x","article-title":"Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study","volume":"108","author":"Matsumoto","year":"2011","journal-title":"BJU Int"},{"issue":"12","key":"10.1016\/j.hoc.2014.10.003_bib35","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1111\/j.1464-410X.2009.09072.x","article-title":"Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy","volume":"105","author":"Shariat","year":"2010","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.hoc.2014.10.003_bib36","first-page":"468","article-title":"Prediction of true nodal status in patients with pathological lymph node negative upper tract urothelial carcinoma at radical nephroureterectomy","volume":"189","author":"Xylinas","year":"2013","journal-title":"J\u00a0Urol"},{"issue":"4","key":"10.1016\/j.hoc.2014.10.003_bib37","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.eururo.2011.07.009","article-title":"Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer","volume":"60","author":"Roscigno","year":"2011","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.hoc.2014.10.003_bib38","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.urology.2006.10.014","article-title":"Primary site and incidence of lymph node metastases in urothelial carcinoma of upper urinary tract","volume":"69","author":"Kondo","year":"2007","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.hoc.2014.10.003_bib39","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.eururo.2011.09.017","article-title":"The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy","volume":"61","author":"Chromecki","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.hoc.2014.10.003_bib40","article-title":"Influence of preoperative factors on the oncologic outcome for upper urinary tract urothelial carcinoma after radical nephroureterectomy","author":"Hurel","year":"2014","journal-title":"World J Urol"},{"issue":"12","key":"10.1016\/j.hoc.2014.10.003_bib41","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1016\/j.ejca.2013.04.016","article-title":"Lymphovascular invasion as a prognostic factor in the upper urinary tract urothelial carcinoma: a systematic review and meta-analysis","volume":"49","author":"Ku","year":"2013","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.hoc.2014.10.003_bib42","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.eururo.2009.12.029","article-title":"Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study","volume":"57","author":"Novara","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.hoc.2014.10.003_bib43","article-title":"Risk stratification for bladder recurrence of upper urinary tract urothelial carcinoma after radical nephroureterectomy","author":"Ishioka","year":"2014","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.hoc.2014.10.003_bib44","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.urolonc.2013.11.006","article-title":"Effect of tumor size on recurrence-free survival of upper tract urothelial carcinoma following surgical resection","volume":"32","author":"Espiritu","year":"2014","journal-title":"Urol Oncol"},{"issue":"4","key":"10.1016\/j.hoc.2014.10.003_bib45","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.eururo.2012.01.021","article-title":"Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma","volume":"61","author":"Cha","year":"2012","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.hoc.2014.10.003_bib46","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.eururo.2009.11.035","article-title":"Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract","volume":"57","author":"Zigeuner","year":"2010","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.hoc.2014.10.003_bib47","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00345-012-0964-4","article-title":"Influence of preoperative hydronephrosis on the outcome of urothelial carcinoma of the upper urinary tract after nephroureterectomy: the results from a multi-institutional French cohort","volume":"31","author":"Bozzini","year":"2013","journal-title":"World J Urol"},{"issue":"1","key":"10.1016\/j.hoc.2014.10.003_bib48","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00345-012-0946-6","article-title":"Distinct patterns and behaviour of urothelial carcinoma with respect to anatomical location: how molecular biomarkers can augment clinico-pathological predictors in upper urinary tract tumours","volume":"31","author":"Yates","year":"2013","journal-title":"World J Urol"},{"issue":"5","key":"10.1016\/j.hoc.2014.10.003_bib49","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/bju.12551","article-title":"Prognostic value of microRNA expression pattern in upper tract urothelial carcinoma","volume":"113","author":"Izquierdo","year":"2014","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.hoc.2014.10.003_bib50","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.eururo.2013.12.008","article-title":"Insulin-like growth factor messenger RNA-binding protein 3 expression helps prognostication in patients with upper tract urothelial carcinoma","volume":"66","author":"Lee","year":"2014","journal-title":"Eur Urol"},{"issue":"7","key":"10.1016\/j.hoc.2014.10.003_bib51","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/jclinpath-2012-201278","article-title":"IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder","volume":"66","author":"Liang","year":"2013","journal-title":"J\u00a0Clin Pathol"},{"issue":"11","key":"10.1016\/j.hoc.2014.10.003_bib52","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1038\/bjc.2013.216","article-title":"Prognostic significance of Bcl-xL expression and efficacy of Bcl-xL targeting therapy in urothelial carcinoma","volume":"108","author":"Yoshimine","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.hoc.2014.10.003_bib53","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/1471-2407-14-363","article-title":"A\u00a0panel of tumor markers, calreticulin, annexin A2, and annexin A3 in upper tract urothelial carcinoma identified by proteomic and immunological analysis","volume":"14","author":"Lu","year":"2014","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.hoc.2014.10.003_bib54","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1016\/j.humpath.2013.07.006","article-title":"The role of GATA binding protein 3 in the differential diagnosis of collecting duct and upper tract urothelial carcinomas","volume":"44","author":"Gonzalez-Roibon","year":"2013","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.hoc.2014.10.003_bib55","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ejca.2013.08.025","article-title":"Accurate detection of upper tract urothelial carcinoma in tissue and urine by means of quantitative GDF15, TMEFF2 and VIM promoter methylation","volume":"50","author":"Monteiro-Reis","year":"2014","journal-title":"Eur J Cancer"},{"issue":"12","key":"10.1016\/j.hoc.2014.10.003_bib56","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1245\/s10434-014-3830-3","article-title":"A\u00a0multi-institutional validation of the prognostic value of the neutrophil-to-lymphocyte ratio for upper tract urothelial carcinoma treated with radical nephroureterectomy","volume":"21","author":"Tanaka","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hoc.2014.10.003_bib57","article-title":"Clinical significance of prognosis of the neutrophil-lymphocyte ratio and erythrocyte sedimentation rate in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma","author":"Sung","year":"2014","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.hoc.2014.10.003_bib58","first-page":"316","article-title":"Impact of preoperative anemia on oncologic outcomes of upper tract urothelial carcinoma treated with radical nephroureterectomy","volume":"191","author":"Rink","year":"2014","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.hoc.2014.10.003_bib59","article-title":"Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma","author":"Rieken","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.hoc.2014.10.003_bib60","article-title":"Preoperative risk stratification for cancer-specific survival of patients with upper urinary tract urothelial carcinoma treated by nephroureterectomy","author":"Fujita","year":"2014","journal-title":"Int J Clin Oncol"},{"issue":"6","key":"10.1016\/j.hoc.2014.10.003_bib61","first-page":"4887","article-title":"Endoscopic management of upper tract urothelial carcinoma","volume":"16","author":"Polcari","year":"2009","journal-title":"Can J Urol"},{"issue":"1","key":"10.1016\/j.hoc.2014.10.003_bib62","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00345-012-0948-4","article-title":"Results and outcomes after endoscopic treatment of upper urinary tract carcinoma: the Austrian experience","volume":"31","author":"Fajkovic","year":"2013","journal-title":"World J Urol"},{"issue":"1","key":"10.1016\/j.hoc.2014.10.003_bib63","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.urology.2011.02.038","article-title":"Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative management","volume":"78","author":"Smith","year":"2011","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.hoc.2014.10.003_bib64","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1464-410X.2012.11068.x","article-title":"Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review","volume":"110","author":"Cutress","year":"2012","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.hoc.2014.10.003_bib65","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11934-013-0305-1","article-title":"Conservative nephron-sparing treatment of upper-tract tumors","volume":"14","author":"Smith","year":"2013","journal-title":"Curr Urol Rep"},{"issue":"1","key":"10.1016\/j.hoc.2014.10.003_bib66","doi-asserted-by":"crossref","first-page":"34.e1","DOI":"10.1016\/j.urolonc.2013.01.001","article-title":"Distal ureterectomy is a safe surgical option in patients with urothelial carcinoma of the distal ureter","volume":"32","author":"Dalpiaz","year":"2014","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2014.10.003_bib67","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1586\/era.11.193","article-title":"Efficacy of instillations with chemotherapy or immunotherapy following endoscopic resection for upper tract urothelial carcinoma","volume":"12","author":"Bachir","year":"2012","journal-title":"Expert Rev Anticancer Ther"},{"issue":"5","key":"10.1016\/j.hoc.2014.10.003_bib68","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.eururo.2011.07.051","article-title":"Antegrade perfusion with bacillus Calmette-Guerin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit?","volume":"60","author":"Giannarini","year":"2011","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.hoc.2014.10.003_bib69","first-page":"145","article-title":"Intracavitary immunotherapy and chemotherapy for upper urinary tract cancer: current evidence","volume":"15","author":"Carmignani","year":"2013","journal-title":"Rev Urol"},{"issue":"3","key":"10.1016\/j.hoc.2014.10.003_bib70","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4103\/0974-7796.115746","article-title":"Mitomycin C instillation following ureterorenoscopic laser ablation of upper urinary tract carcinoma","volume":"5","author":"Aboumarzouk","year":"2013","journal-title":"Urol Ann"},{"issue":"4","key":"10.1016\/j.hoc.2014.10.003_bib71","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.eururo.2011.05.064","article-title":"Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial)","volume":"60","author":"O'Brien","year":"2011","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.hoc.2014.10.003_bib72","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/cncr.24135","article-title":"Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration","volume":"115","author":"Margulis","year":"2009","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.hoc.2014.10.003_bib73","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1089\/end.2006.0306","article-title":"Oncologic outcomes of extravesical stapling of distal ureter in laparoscopic nephroureterectomy","volume":"21","author":"Romero","year":"2007","journal-title":"J\u00a0Endourol"},{"issue":"5","key":"10.1016\/j.hoc.2014.10.003_bib74","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.urology.2008.04.022","article-title":"Management of distal ureter in laparoscopic nephroureterectomy\u2013a comprehensive review of techniques","volume":"72","author":"Macejko","year":"2008","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.hoc.2014.10.003_bib75","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.eururo.2009.12.001","article-title":"Should bladder cuff excision remain the standard of care at nephroureterectomy in patients with urothelial carcinoma of the renal pelvis? A population-based study","volume":"57","author":"Lughezzani","year":"2010","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.hoc.2014.10.003_bib76","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1464-410X.2010.09835.x","article-title":"Does the surgical technique for management of the distal ureter influence the outcome after nephroureterectomy?","volume":"108","author":"Phe","year":"2011","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.hoc.2014.10.003_bib77","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.eururo.2012.04.052","article-title":"Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma","volume":"65","author":"Xylinas","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.hoc.2014.10.003_bib78","doi-asserted-by":"crossref","unstructured":"H.P. McDonald, W.E. Upchurch, C.E. Sturdevant Nephro-ureterectomy: a new technique. J Urol, 67 (1952), pp. 804\u2013809.","DOI":"10.1016\/S0022-5347(17)68422-2"},{"issue":"3","key":"10.1016\/j.hoc.2014.10.003_bib79","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1464-410X.2010.09826.x","article-title":"Oncological outcomes after laparoscopic and open radical nephroureterectomy: results from an international cohort","volume":"108","author":"Walton","year":"2011","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.hoc.2014.10.003_bib80","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1464-410X.2006.06524.x","article-title":"Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: time to change the treatment paradigm?","volume":"98","author":"Brown","year":"2006","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.hoc.2014.10.003_bib81","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.eururo.2007.04.070","article-title":"Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival","volume":"52","author":"Brausi","year":"2007","journal-title":"Eur Urol"},{"issue":"4 Pt 1","key":"10.1016\/j.hoc.2014.10.003_bib82","first-page":"1212","article-title":"Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract","volume":"178","author":"Kondo","year":"2007","journal-title":"J\u00a0Urol"},{"issue":"5","key":"10.1016\/j.hoc.2014.10.003_bib83","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.urology.2009.04.084","article-title":"Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial cancer","volume":"74","author":"Roscigno","year":"2009","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.hoc.2014.10.003_bib84","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.eururo.2009.06.004","article-title":"The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed?","volume":"56","author":"Roscigno","year":"2009","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.hoc.2014.10.003_bib85","first-page":"2482","article-title":"Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy","volume":"181","author":"Roscigno","year":"2009","journal-title":"J\u00a0Urol"},{"issue":"10","key":"10.1016\/j.hoc.2014.10.003_bib86","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1442-2042.2010.02610.x","article-title":"Template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract: impact on patient survival","volume":"17","author":"Kondo","year":"2010","journal-title":"Int J Urol"},{"issue":"4","key":"10.1016\/j.hoc.2014.10.003_bib87","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ucl.2011.07.012","article-title":"The emerging role of lymphadenectomy in upper tract urothelial carcinoma","volume":"38","author":"Weight","year":"2011","journal-title":"Urol Clin North Am"},{"issue":"4","key":"10.1016\/j.hoc.2014.10.003_bib88","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.eururo.2011.12.026","article-title":"Propensity-score-matched comparison of perioperative outcomes between open and laparoscopic nephroureterectomy: a national series","volume":"61","author":"Hanna","year":"2012","journal-title":"Eur Urol"},{"issue":"4 Pt 1","key":"10.1016\/j.hoc.2014.10.003_bib89","first-page":"1301","article-title":"Trocar site recurrence after laparoscopic nephroureterectomy","volume":"170","author":"Ong","year":"2003","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.hoc.2014.10.003_bib90","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00345-008-0349-x","article-title":"Oncological risk of laparoscopic surgery in urothelial carcinomas","volume":"27","author":"Roupret","year":"2009","journal-title":"World J Urol"},{"issue":"6","key":"10.1016\/j.hoc.2014.10.003_bib91","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.eururo.2010.03.025","article-title":"Words of wisdom. Re: laparoscopic versus open nephroureterectomy: perioperative and oncologic outcomes from a randomised prospective study","volume":"57","author":"Greco","year":"2010","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.hoc.2014.10.003_bib92","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.eururo.2009.06.013","article-title":"Laparoscopic versus open nephroureterectomy: perioperative and oncologic outcomes from a randomised prospective study","volume":"56","author":"Simone","year":"2009","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.hoc.2014.10.003_bib93","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.eururo.2012.02.019","article-title":"Laparoscopic versus open nephroureterectomy for the treatment of upper urinary tract urothelial carcinoma: a systematic review and cumulative analysis of comparative studies","volume":"61","author":"Ni","year":"2012","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.hoc.2014.10.003_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eururo.2009.03.072","article-title":"Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases","volume":"56","author":"Capitanio","year":"2009","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.hoc.2014.10.003_bib95","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.eururo.2010.08.005","article-title":"Comparison between laparoscopic and open radical nephroureterectomy in a contemporary group of patients: are recurrence and disease-specific survival associated with surgical technique?","volume":"58","author":"Favaretto","year":"2010","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.hoc.2014.10.003_bib96","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.eururo.2004.08.006","article-title":"Laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: is it better than open surgery?","volume":"46","author":"Rassweiler","year":"2004","journal-title":"Eur Urol"},{"issue":"8","key":"10.1016\/j.hoc.2014.10.003_bib97","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1089\/end.2011.0223","article-title":"Long-term comparative outcomes of open versus laparoscopic nephroureterectomy for upper urinary tract urothelial-cell carcinoma after a median follow-up of 13 years","volume":"25","author":"Stewart","year":"2011","journal-title":"J\u00a0Endourol"},{"issue":"2","key":"10.1016\/j.hoc.2014.10.003_bib98","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s11934-012-0303-8","article-title":"Current status of robot assisted laparoscopic radical nephroureterectomy for management of upper tract urothelial carcinoma","volume":"14","author":"Lim","year":"2013","journal-title":"Curr Urol Rep"},{"issue":"1","key":"10.1016\/j.hoc.2014.10.003_bib99","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.eururo.2013.08.033","article-title":"Adjuvant chemotherapy for invasive bladder cancer: a 2013 updated systematic review and meta-analysis of randomized trials","volume":"66","author":"Leow","year":"2014","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.hoc.2014.10.003_bib100","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.eururo.2012.08.010","article-title":"ICUD-EAU International Consultation on Bladder Cancer 2012: chemotherapy for urothelial carcinoma-neoadjuvant and adjuvant settings","volume":"63","author":"Sternberg","year":"2013","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.hoc.2014.10.003_bib101","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.eururo.2014.03.003","article-title":"A\u00a0systematic review and meta-analysis of adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma","volume":"66","author":"Leow","year":"2014","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.hoc.2014.10.003_bib102","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/cncr.27751","article-title":"A\u00a0phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer: final results","volume":"119","author":"Siefker-Radtke","year":"2013","journal-title":"Cancer"},{"issue":"Suppl 5","key":"10.1016\/j.hoc.2014.10.003_bib103","article-title":"Neoadjuvant chemotherapy with DDMVAC and bevacizumab in high-risk urothelial cancer: results from a phase II trial at the M. D. Anderson Cancer Center","volume":"30","author":"Siefker-Radtke","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.hoc.2014.10.003_bib104","first-page":"900","article-title":"Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration","volume":"182","author":"Hellenthal","year":"2009","journal-title":"J\u00a0Urol"},{"issue":"5","key":"10.1016\/j.hoc.2014.10.003_bib105","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s00345-011-0775-z","article-title":"The result of adjuvant chemotherapy for localized pT3 upper urinary tract carcinoma in a multi-institutional study","volume":"30","author":"Kawashima","year":"2012","journal-title":"World J Urol"},{"issue":"8","key":"10.1016\/j.hoc.2014.10.003_bib106","first-page":"686","article-title":"The efficacy of adjuvant chemotherapy for locally advanced upper tract urothelial cell carcinoma","volume":"4","author":"Kim","year":"2013","journal-title":"J\u00a0Cancer"},{"issue":"1","key":"10.1016\/j.hoc.2014.10.003_bib107","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.urology.2006.01.053","article-title":"Adjuvant systemic chemotherapy in the treatment of patients with invasive transitional cell carcinoma of the upper urinary tract","volume":"68","author":"Kwak","year":"2006","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.hoc.2014.10.003_bib108","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000092930","article-title":"Adjuvant chemotherapy in the management of pT3N0M0 transitional cell carcinoma of the upper urinary tract","volume":"77","author":"Lee","year":"2006","journal-title":"Urol Int"},{"issue":"9","key":"10.1016\/j.hoc.2014.10.003_bib109","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1442-2042.2008.02114.x","article-title":"Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma","volume":"15","author":"Soga","year":"2008","journal-title":"Int J Urol"},{"issue":"7","key":"10.1016\/j.hoc.2014.10.003_bib110","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1442-2042.2004.00841.x","article-title":"Impact of adjuvant systemic chemotherapy on postoperative survival in patients with high-risk urothelial cancer","volume":"11","author":"Suzuki","year":"2004","journal-title":"Int J Urol"},{"issue":"24","key":"10.1016\/j.hoc.2014.10.003_bib111","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1002\/cncr.26172","article-title":"Outcomes after adjuvant chemotherapy in the treatment of high-risk urothelial carcinoma of the upper urinary tract (UUT-UC): results from a large multicenter collaborative study","volume":"117","author":"Vassilakopoulou","year":"2011","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.hoc.2014.10.003_bib112","doi-asserted-by":"crossref","first-page":"31.e17","DOI":"10.1016\/j.urolonc.2012.11.014","article-title":"Adjuvant chemotherapy for upper-tract\u00a0urothelial carcinoma treated with nephroureterectomy: assessment of adequate renal function and influence on outcome","volume":"32","author":"Yafi","year":"2014","journal-title":"Urol Oncol"},{"issue":"3 Pt 1","key":"10.1016\/j.hoc.2014.10.003_bib113","first-page":"703","article-title":"Advanced transitional cell carcinoma of the upper urinary tract: patterns of failure, survival and impact of postoperative adjuvant radiotherapy","volume":"160","author":"Hall","year":"1998","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.hoc.2014.10.003_bib114","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/1471-2407-11-297","article-title":"Radiotherapy may improve overall survival of patients with T3\/T4 transitional cell carcinoma of the renal pelvis or ureter and delay bladder tumour relapse","volume":"11","author":"Chen","year":"2011","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.hoc.2014.10.003_bib115","first-page":"247","article-title":"Adjuvant and salvage radiotherapy for urothelial cell carcinoma of the upper urinary tract: experience in a single institution","volume":"35","author":"Fan","year":"2012","journal-title":"Chang Gung Med J"},{"issue":"4 Pt 1","key":"10.1016\/j.hoc.2014.10.003_bib116","first-page":"1271","article-title":"Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter","volume":"172","author":"Czito","year":"2004","journal-title":"J\u00a0Urol"},{"issue":"4","key":"10.1016\/j.hoc.2014.10.003_bib117","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/0360-3016(92)90723-U","article-title":"Adjuvant radiotherapy in high stage transitional cell carcinoma of the renal pelvis and ureter","volume":"24","author":"Cozad","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.hoc.2014.10.003_bib118","first-page":"115","article-title":"Postoperative radiation therapy in 26 patients with invasive transitional cell carcinoma of the upper urinary tract: no impact on survival?","volume":"155","author":"Maulard-Durdux","year":"1996","journal-title":"J\u00a0Urol"},{"issue":"11","key":"10.1016\/j.hoc.2014.10.003_bib119","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/pd.214","article-title":"Normal and abnormal development of the urogenital tract","volume":"21","author":"Cuckow","year":"2001","journal-title":"Prenat Diagn"},{"issue":"2\u20133","key":"10.1016\/j.hoc.2014.10.003_bib120","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ejcb.2004.12.011","article-title":"Urothelial umbrella cells of human ureter are heterogeneous with respect to their uroplakin composition: different degrees of urothelial maturity in ureter and bladder?","volume":"84","author":"Riedel","year":"2005","journal-title":"Eur J Cell Biol"},{"issue":"2","key":"10.1016\/j.hoc.2014.10.003_bib121","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/jcp.20140","article-title":"Spreading of embryologically distinct urothelial cells is inhibited by SPARC","volume":"202","author":"Hudson","year":"2005","journal-title":"J\u00a0Cell Physiol"},{"issue":"13","key":"10.1016\/j.hoc.2014.10.003_bib122","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1200\/JCO.2005.03.163","article-title":"Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma","volume":"23","author":"Catto","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.hoc.2014.10.003_bib123","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s11912-014-0404-2","article-title":"Optimal treatment for metastatic bladder cancer","volume":"16","author":"Carballido","year":"2014","journal-title":"Curr Oncol Rep"},{"issue":"4","key":"10.1016\/j.hoc.2014.10.003_bib124","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.urolonc.2010.07.016","article-title":"The role of chemotherapy in the treatment of urothelial cell carcinoma of the upper urinary tract (UUT-UCC)","volume":"31","author":"Audenet","year":"2013","journal-title":"Urol Oncol"},{"issue":"3","key":"10.1016\/j.hoc.2014.10.003_bib125","first-page":"461","article-title":"M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium","volume":"139","author":"Sternberg","year":"1988","journal-title":"J\u00a0Urol"},{"issue":"17","key":"10.1016\/j.hoc.2014.10.003_bib126","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1200\/JCO.2011.34.8433","article-title":"Treatment of patients with metastatic urothelial cancer \u201cunfit\u201d for Cisplatin-based chemotherapy","volume":"29","author":"Galsky","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"10.1016\/j.hoc.2014.10.003_bib127","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.ejca.2012.04.002","article-title":"Cisplatin and gemcitabine administered every two weeks in patients with locally advanced or metastatic urothelial carcinoma and impaired renal function","volume":"48","author":"Morales-Barrera","year":"2012","journal-title":"Eur J Cancer"},{"issue":"17","key":"10.1016\/j.hoc.2014.10.003_bib128","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1200\/JCO.2000.18.17.3068","article-title":"Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study","volume":"18","author":"von der Maase","year":"2000","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2014.10.003_bib129","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.eururo.2006.12.029","article-title":"Gemcitabine plus cisplatin versus gemcitabine plus carboplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium: results of a randomized phase 2 trial","volume":"52","author":"Dogliotti","year":"2007","journal-title":"Eur Urol"},{"issue":"10","key":"10.1016\/j.hoc.2014.10.003_bib130","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/(SICI)1097-0142(19971115)80:10<1966::AID-CNCR14>3.0.CO;2-W","article-title":"Carboplatin-based versus cisplatin-based chemotherapy in the treatment of surgically incurable advanced bladder carcinoma","volume":"80","author":"Bellmunt","year":"1997","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.hoc.2014.10.003_bib131","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1200\/JCO.2001.19.10.2638","volume":"19","author":"Sternberg","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"issue":"18","key":"10.1016\/j.hoc.2014.10.003_bib132","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1200\/JCO.2013.52.4785","article-title":"Neoadjuvant dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin with pegfilgrastim support in muscle-invasive urothelial cancer: pathologic, radiologic, and biomarker correlates","volume":"32","author":"Choueiri","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"18","key":"10.1016\/j.hoc.2014.10.003_bib133","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1200\/JCO.2013.53.2465","article-title":"Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: results of a multicenter phase II study with molecular correlates of response and toxicity","volume":"32","author":"Plimack","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"S4","key":"10.1016\/j.hoc.2014.10.003_bib134","article-title":"Neoadjuvant accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) in patients with high-grade upper-tract urothelial carcinoma","volume":"32","author":"Hoffman-Censits","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.hoc.2014.10.003_bib135","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1053\/j.seminoncol.2004.11.013","article-title":"Palliative radiation therapy","volume":"32","author":"Konski","year":"2005","journal-title":"Semin Oncol"},{"issue":"2","key":"10.1016\/j.hoc.2014.10.003_bib136","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0360-3016(00)00430-2","article-title":"A\u00a0randomized trial of hypofractionated schedules of palliative radiotherapy in the management of bladder carcinoma: results of medical research council trial BA09","volume":"47","author":"Duchesne","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.hoc.2014.10.003_bib137","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0167-8140(97)01943-9","article-title":"Hypofractionated radiotherapy for muscle invasive bladder cancer in the elderly","volume":"43","author":"McLaren","year":"1997","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.hoc.2014.10.003_bib138","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/0090-4295(82)90462-9","article-title":"Long-term results following thoracotomy for metastatic bladder cancer","volume":"20","author":"Cowles","year":"1982","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.hoc.2014.10.003_bib139","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.eururo.2007.02.052","article-title":"Impact of multimodal treatment on survival in patients with metastatic urothelial cancer","volume":"52","author":"Abe","year":"2007","journal-title":"Eur Urol"},{"issue":"8","key":"10.1016\/j.hoc.2014.10.003_bib140","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1200\/JCO.1999.17.8.2546","article-title":"Outcome of postchemotherapy surgery after treatment with methotrexate, vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma","volume":"17","author":"Dodd","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.hoc.2014.10.003_bib141","first-page":"811","article-title":"Post-chemotherapy surgery in patients with unresectable or regionally metastatic bladder cancer","volume":"165","author":"Herr","year":"2001","journal-title":"J\u00a0Urol"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858814001440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858814001440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:01:59Z","timestamp":1760184119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858814001440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":141,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0889858814001440"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2014.10.003","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and Management of Upper Tract Urothelial Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2014.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}